LEDERMAN SETH — SEC Form 4 filings
SEC reporting owner CIK 1563420. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-31.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-29 to 2026-08-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 31,000 shares, $459,180 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 15,000 shares @ $14.89 ($223,350) in Tonix Pharmaceuticals Holding Corp., filed 2026-03-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Executive Officer, Director | 9 | 5 legs · 31,000 sh · $459,180 | — | 13 |
Form 4 filings — LEDERMAN SETH
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-31 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Purchase (P): 2,000 @ $13.79 | EDGAR |
| 2026-06-09 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Purchase (P): 5,000 @ $11.79 | EDGAR |
| 2026-04-01 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Purchase (P): 5,000 @ $12.62 | EDGAR |
| 2026-03-18 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Purchase (P): 15,000 @ $14.89 | EDGAR |
| 2026-02-26 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/award (A): 134,504 (derivative) @ $0 · Grant/award (A): 134,503 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Purchase (P): 4,000 @ $21.55 | EDGAR |
| 2025-02-27 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Other (J): 5.18 @ $3.38 · Other (J): 0.22 @ $3.30 · Other (J): 1 @ $0.15 · Grant/award (A): 123,958 (derivative) @ $0 · Grant/award (A): 123,958 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4/A | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/award (A): 235,320 (derivative) @ $0 · Grant/award (A): 1,903,680 (derivative) @ $0 · Grant/award (A): 1,309,911 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/award (A): 235,320 (derivative) @ $0 · Grant/award (A): 1,903,680 (derivative) @ $0 · Grant/award (A): 1,309,911 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1563420 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →